GLOBAL HEALTH LIMITED (MEDANTA) financials

GLOBAL HEALTH LIMITED (MEDANTA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Market Cap: ₹33,268Cr.
Current Price: ₹1,238
Stock P/E: 67.0
ROE: 13.2%
ROCE: 16.4%
Book Value: ₹149
Dividend Yield: 0.04%
52W High / Low: ₹1,544/955

In Jun 2026, GLOBAL HEALTH LIMITED (MEDANTA) reported sales ₹1,079 Cr and net profit ₹137 Cr.

Annual TTM: sales ₹3,906 Cr, net profit ₹482 Cr.

Shareholding: Promoters 33.00% (Jun 2026), FIIs 9.46% (Jun 2026), DIIs 16.89% (Jun 2026), Public 40.55% (Jun 2026), Others 0.09% (Jun 2026).

MEDANTA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	665	812	803	882	926	940	961	1,079
Expenses	514	611	608	688	734	766	767	849
Operating Profit	150	202	195	195	193	174	193	230
OPM %	23%	25%	24%	22%	21%	19%	20%	21%
Other Income	24	19	-24	43	39	-11	36	24
Interest	5	8	7	6	9	13	13	16
Depreciation	25	37	38	33	37	48	52	55
Profit before tax	144	175	126	198	185	103	163	183
Tax %	27%	25%	26%	23%	24%	22%	24%	25%
Net Profit	104	131	93	152	140	80	124	137
EPS in Rs	3.89	4.89	3.48	5.65	5.22	2.97	4.62	5.11
Raw PDF	—	—	—	—	—	—	—	—

MEDANTA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,472	1,227	1,765	1,974	2,975	3,204	3,709	3,906
Expenses	1,253	1,054	1,384	1,551	2,222	2,432	2,946	3,116
Operating Profit	219	173	381	423	753	772	764	790
OPM %	15%	14%	22%	21%	25%	24%	21%	20%
Other Income	43	28	35	47	91	41	107	88
Interest	33	29	33	32	51	41	50	51
Depreciation	99	88	87	86	134	150	171	192
Profit before tax	131	84	296	352	659	623	650	635
Tax %	22%	32%	26%	25%	26%	26%	24%	—
Net Profit	103	57	219	263	486	462	496	482
EPS in Rs	4.17	2.31	8.64	9.82	18.11	17.18	18.46	17.92
Dividend Payout %	0%	0%	0%	0%	0%	0%	3%	—

MEDANTA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	49	49	50	51	54	54	54	54
Reserves	1,230	1,341	1,434	1,689	2,435	2,983	3,444	3,959
Borrowings	168	51	228	308	288	424	337	683
Other Liabilities	310	517	291	314	402	523	606	656
Total Liabilities	1,758	1,958	2,002	2,361	3,179	3,984	4,441	5,351
Fixed Assets	869	929	851	827	810	1,645	1,861	2,903
CWIP	5	3	4	6	75	280	458	120
Investments	356	500	626	734	765	362	366	389
Other Assets	528	525	521	794	1,529	1,698	1,757	1,939
Total Assets	1,758	1,958	2,002	2,361	3,179	3,984	4,441	5,351

MEDANTA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	152	193	201	235	431	559	528	573
Cash from Investing Activity	-104	-45	-250	-313	-257	-519	-638	-931
Cash from Financing Activity	-49	-56	-37	98	404	-379	-94	264
Net Cash Flow	-1	92	-86	20	577	-339	-205	-94
Free Cash Flow	123	176	178	171	315	335	102	-102
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	153%	114%	125%	86%	126%	97%	89%	89%

MEDANTA shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	33.04%	33.03%	33.03%	33.01%	33.01%	33.01%	33.01%	33.00%
FIIs	12.21%	12.48%	11.76%	11.54%	11.41%	10.54%	10.15%	9.46%
DIIs	11.11%	10.51%	11.93%	12.20%	12.97%	13.99%	14.76%	16.89%
Public	43.64%	43.98%	43.28%	43.19%	42.56%	42.41%	42.01%	40.55%
Others	0.00%	0.00%	0.00%	0.06%	0.06%	0.06%	0.08%	0.09%
No. of Shareholders	1,49,722	1,48,633	1,54,688	1,56,372	1,55,806	1,51,241	1,47,390	1,40,531

MEDANTA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	42	37	39	36	32	26	33	38
Inventory Days	26	37	39	33	34	29	24	23
Days Payable	142	135	134	84	113	84	81	93
Cash Conversion Cycle	-74	-61	-56	-16	-48	-29	-24	-32
Working Capital Days	-7	-11	-20	-6	-27	-24	-14	-4
ROCE %	8%	11%	7%	17%	16%	23%	20%	16%

MEDANTAUpdated 19 Oct 2026, 22:11

Global Health Limited

MEDANTAUpdated 19 Oct 2026, 22:11

Market Cap

₹33,268Cr.

Current Price

₹1,238

High / Low

₹1,544/955

Stock P/E

67.0

ROE13.2%

ROCE16.4%

Book Value₹149

Face Value₹2.00

Dividend Yield0.04%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	551	6	435	27	20	116	26	86	3.21
Sep 2023	580	6	452	26	22	127	25	95	3.54
Dec 2023	565	6	439	23	22	121	28	87	3.25
Mar 2024	724	10	560	30	35	149	26	109	4.08
Jun 2024	611	6	479	27	23	130	26	96	3.59
Sep 2024	665	5	514	24	25	144	27	104	3.89
Dec 2024	812	8	611	19	37	175	25	131	4.89
Mar 2025	803	7	608	-24	38	126	26	93	3.48
Jun 2025	882	6	688	43	33	198	23	152	5.65
Sep 2025	926	9	734	39	37	185	24	140	5.22
Dec 2025	940	13	766	-11	48	103	22	80	2.97
Mar 2026	961	13	767	36	52	163	24	124	4.62
Jun 2026	1079	16	849	24	55	183	25	137	5.11

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2017	1277	19	1158	67	77	89	39	54	2.24
Mar 2018	1343	24	1218	49	86	64	42	37	1.54
Mar 2019	1441	21	1297	64	91	97	35	63	2.56
Mar 2020	1472	33	1253	43	99	131	22	103	4.17
Mar 2021	1227	29	1054	28	88	84	32	57	2.31
Mar 2022	1765	33	1384	35	87	296	26	219	8.64
Mar 2023	1974	32	1551	47	86	352	25	263	9.82
Mar 2024	2975	51	2222	91	134	659	26	486	18.11
Mar 2025	3204	41	2432	41	150	623	26	462	17.18
Mar 2026	3709	50	2946	107	171	650	24	496	18.46
TTM	3906	51	3116	88	192	635	—	482	17.92

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	33%
FIIs	9.46%
DIIs	16.89%
Public	40.55%
Others	0.09%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public	Others
Sep 2023	33.06%	10.69%	10.93%	45.31%	0%
Dec 2023	33.05%	11.36%	11.15%	44.45%	0%
Mar 2024	33.04%	12.1%	10.25%	44.6%	0%
Jun 2024	33.04%	12.94%	10.57%	43.44%	0%
Sep 2024	33.04%	12.21%	11.11%	43.64%	0%
Dec 2024	33.03%	12.48%	10.51%	43.98%	0%
Mar 2025	33.03%	11.76%	11.93%	43.28%	0%
Jun 2025	33.01%	11.54%	12.2%	43.19%	0.06%
Sep 2025	33.01%	11.41%	12.97%	42.56%	0.06%
Dec 2025	33.01%	10.54%	13.99%	42.41%	0.06%
Mar 2026	33.01%	10.15%	14.76%	42.01%	0.08%
Jun 2026	33%	9.46%	16.89%	40.55%	0.09%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2017	48	1070	215	303	1637	966	8	21	642	1637
Mar 2018	48	1141	201	318	1709	1162	7	0	540	1709
Mar 2019	49	1230	168	310	1758	869	5	356	528	1758
Mar 2020	49	1341	51	517	1958	929	3	500	525	1958
Mar 2021	50	1434	228	291	2002	851	4	626	521	2002
Mar 2022	51	1689	308	314	2361	827	6	734	794	2361
Mar 2023	54	2435	288	402	3179	810	75	765	1529	3179
Mar 2024	54	2983	424	523	3984	1645	280	362	1698	3984
Mar 2025	54	3444	337	606	4441	1861	458	366	1757	4441
Mar 2026	54	3959	683	656	5351	2903	120	389	1939	5351

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2017	124	-112	-6	6
Mar 2018	—	—	—	—
Mar 2019	152	-104	-49	-1
Mar 2020	193	-45	-56	92
Mar 2021	201	-250	-37	-86
Mar 2022	235	-313	98	20
Mar 2023	431	-257	404	577
Mar 2024	559	-519	-379	-339
Mar 2025	528	-638	-94	-205
Mar 2026	573	-931	264	-94

Key ratios

Historical financial ratios

Category	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	31	41	42	37	39	36	32	26	33	38
Inventory Days	36	26	26	37	39	33	34	29	24	23
Days Payable	132	124	142	135	134	84	113	84	81	93
Cash Conversion Cycle	-66	-56	-74	-61	-56	-16	-48	-29	-24	-32
Working Capital Days	-31	-16	-7	-11	-20	-6	-27	-24	-14	-4
ROCE %	—	6%	8%	11%	7%	17%	16%	23%	20%	16%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of GLOBAL HEALTH LIMITED (MEDANTA)?

The reported market capitalisation for GLOBAL HEALTH LIMITED (MEDANTA) is ₹33,268Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MEDANTA?

The current price shown for GLOBAL HEALTH LIMITED (MEDANTA) on Fincrux is ₹1,238 with a 52-week high/low of ₹1,544/955.

What is the P/E ratio of GLOBAL HEALTH LIMITED (MEDANTA)?

The stock P/E for GLOBAL HEALTH LIMITED (MEDANTA) is 67.0 on Fincrux, with ROE at 13.2% and ROCE at 16.4%.

What were MEDANTA latest quarterly results?

For Jun 2026, GLOBAL HEALTH LIMITED (MEDANTA) reported sales ₹1,079 Cr and net profit ₹137 Cr (figures in ₹ crore unless noted).

What are MEDANTA annual sales and net profit?

For TTM, GLOBAL HEALTH LIMITED (MEDANTA) shows sales of ₹3,906 Cr and net profit of ₹482 Cr on the Fincrux profit & loss statement.

Who owns GLOBAL HEALTH LIMITED (MEDANTA)?

Latest shareholding for GLOBAL HEALTH LIMITED (MEDANTA) on Fincrux: Promoters 33.00% (Jun 2026), FIIs 9.46% (Jun 2026), DIIs 16.89% (Jun 2026), Public 40.55% (Jun 2026), Others 0.09% (Jun 2026).

Where can I find GLOBAL HEALTH LIMITED (MEDANTA) financials?

GLOBAL HEALTH LIMITED (MEDANTA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MEDANTA balance sheet and cash flow?

Yes. The GLOBAL HEALTH LIMITED (MEDANTA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 22:11